Lizardi-Cervera J, Cuéllar-Gamboa L, Motola-Kuba D

Language: English
References: 21
Page: 206-211
PDF size: 201.06 Kb.

Text Extraction

Focal Nodular Hyperplasia (FNH) and Hepatic Adenoma (HA) are a benign tumors of the liver. The association with the use of oral contraception in women in middle age has been mentioned. This benign liver tumors are relatively rare lesions and are usually unrelated to subjective symptoms. They are increasingly being diagnosed as a result of the widespread use of ultrasound, computed tomography and magnetic resonance in the evaluation of patients with non-specific abdominal symptoms

REFERENCES

1. Langrehr JM, Pfitzmann R, Hermann M, Radke C, et al Hepatocellular carcinoma in association with hepatic focal hyperplasia. Acta Radiol 2006; 47: 340-44.

2. Vilgrim V. Focal nodular hyperplasia: European Journal of Radiografy 2006; 58: 236-245.

3. Craig JR, Peters RL, Endomonson HA. Tumors of the liver and intrahepatic bile ducts. IN: Armesd Forces Institute of Pathology, editor. Atlas of tumor pathology, second series fascicle, Washington: Armes Forces Institute of Pathology; 1989: 26.

4. Kerlin P, Davis GL, Mc Gill. Hepatic adenoma and focal nodal hyperplasia: clinical pathologic, and radiologic features. Gastroenterology 1983; 84: 994-1002.

5. Frederick C, Cobey MD. A review of liver masses in pregnancy and proposed algorithm for their disgnosis and management. Departmen of Surgery, Section of Surgical Oncology, Yale University School of Medicine, TMP 202-333.

6. Medical Staff Conference, University of California, San Francisco: Oral Contraceptives and benign tumors of the liver. West J Med 1984; 140: 260-267.

7. Baum JK, Bookstein JJ, Holtz F, et al. Possible association between benign hepatomas and oral contraceptives. Lancet 1973; 27(2): 926-929.

8. Knowles DM, Casarella WJ, Johson PM, et al: The clinic, radiologic and pathologic characterization of benign hepatic neoplams. Medicine (Baltimore) 1978; 57: 223-37.

9. Lesch R, Hoppe-Seyler P, Heissmeyer HH, Hoeensch D, Jenss H. Oral contraceptives and benign tumors conditions of the liver. Radiologe 1980; 20(12): 565-76

10. Kew MC. Hepatic Tumors and Cist. In Sleisenger & Fordtrans. Gastrintestinal and Liver Disease. 6th Ed. 1998; 2: 1377-80.

11. John F, Gibbs JF, Litwin A. Contemporary management of benign live tumors. Surg Clin N Am 2004; 84: 463-480.

12. Gibbs JF, Litwin AM, Kahlenberg MS. Contemporary Management of the benign liver tumors. Surg Clin N Am 2004; 48: 463-80.

13. Foster JM, Ltiwin A, Gibbs JF et al. Diagnosis regenerative Nodular Hyperplasia, the “Great Masquerader” of liver tumors. J Gastrointest Surg 2006; 10(5): 727-33.

14. Kamel IR, Liapi E, Fishman EK. Focal Nodular Hyperplasia: Lesion evaluation using 16-MDCT and 3D CT angiography. AJR 2006; 186: 1587-1595.

15. Kim J, Ahmad SA, Lowy AM, et al. An algorithm for the accurate identification of benign liver lesions. Am J Surg 2004; 187: 274-279.

16. LaBrecque DR. Mass Lessions & Neoplasia of the liver. In Currenet Diagnosis and Treatment in Gastroenterology, McGraw-Hill Ed. 2003: 696-726.

17. Shortell CK, Schawrtz SL. Hepatic adenoma and focal hyperplasia. Surg Gynecol Obstet 1991; 14(5): 628-34.

18. Kammula US, Buell JF, Labow DM, Rosen S, Millis JM, Posner MC. Surgical management of benign tumors of the liver. Int J Gastrointest Cancer 2001; 30(3): 141-6.

19. Karhunen PJ. Benign hepatic tumors and tumors like conditions in men. J Clin Pathol 1986; 39: 183-8.

20. Ito K, Honko K, Fujita T, Awaya H, Matsumoto T, Matsunaga N, et al. Liver neoplasms: Diagnostics pitfalls. Radiographics 1996: 16(2): 273-93.

21. Crawford JM. Pathologic assessment of liver cells dysplasia and benign liver tumors: differentiation from malignant tumors. Semin Diag Pathol 1990; 7(2): 115-28.